MedTrace Logo

Clinical Investigation of K'Watch - Lab & Home Study

NCT05093569 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2022-05-02

No results posted yet for this study

Summary

This study categorized as a non significant risk trial is a monocentric, prospective, open-label comparative, paired-design trial aims to evaluate the performance and the tolerance of K'Watch CGM system in comparison with conventional reference (YSI system, BGM system and CGM systems ) . This trial will be conducted on patients with Type 1 and 2 of diabetes for 8 days.

Conditions

Interventions

DEVICE

K'watch

Patients

Sponsors & Collaborators

  • PKvitality

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-15
Primary Completion
2022-12-30
Completion
2022-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05093569 on ClinicalTrials.gov